Medicare Enrolled

Dr. Paul Damski, MD

Neurology · South Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
7330 SW 62ND PL STE 200, South Miami, FL 33143
3054656378
In practice since 2006 (20 years)
NPI: 1700853884 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Damski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Damski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Damski

Dr. Paul Damski is a neurology in South Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Damski performed 884 Medicare services across 697 unique beneficiaries.

Between the years covered by Open Payments, Dr. Damski received a total of $6,643 from 60 pharmaceutical and/or device companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Damski is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 33% volume in FL$ $6,643 industry payments

Medicare Practice Summary

Medicare Utilization ↗
884
Medicare services
Top 33% in FL for neurology
697
Unique beneficiaries
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~44 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)320$104$562
Initial hospital admission, moderate complexity97$113$596
Office visit, established patient, complex (40-54 min)76$149$788
New patient office visit (45-59 min)71$133$730
Initial hospital admission, high complexity71$148$870
Hospital follow-up visit, moderate complexity49$68$312
EEG, extended monitoring34$46$344
New patient office visit, complex (60-74 min)31$174$976
Hospital follow-up visit, low complexity28$44$166
Needle measurement of electrical activity in arm or leg muscles, complete study26$91$473
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes19$74$453
Transitional care management services for problem of at least moderate complexity18$172$707
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes17$230$1,021
Hospital follow-up visit, high complexity14$103$448
Office visit, established patient (20-29 min)13$71$397
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,643
Total received (2018-2024)
Avg $949/year across 7 years
Top 34% in FL for neurology
60
Companies
343
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,422 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$221 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$51
2023
$157
2022
$253
2021
$1,834
2020
$1,830
2019
$1,413
2018
$1,104

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$978
UCB, Inc.
$954
Adamas Pharmaceuticals, Inc.
$408
Novartis Pharmaceuticals Corporation
$326
Teva Pharmaceuticals USA, Inc.
$315
Acorda Therapeutics, Inc
$283
Mallinckrodt Hospital Products Inc.
$249
Allergan Inc.
$238
ABBVIE INC.
$198
NOVARTIS PHARMACEUTICALS CORPORATION
$195
AbbVie Inc.
$186
Lilly USA, LLC
$144
Upsher-Smith Laboratories LLC
$119
Mitsubishi Tanabe Pharma America, Inc.
$114
Biogen, Inc.
$110
Allergan, Inc.
$87
Neurocrine Biosciences, Inc.
$80
Alexion Pharmaceuticals, Inc.
$77
ACADIA Pharmaceuticals Inc
$77
Bayer HealthCare Pharmaceuticals Inc.
$76
HARMONY BIOSCIENCES LLC
$74
Zyla Life Sciences
$71
AQUESTIVE THERAPEUTICS, INC.
$71
Greenwich Biosciences, Inc.
$69
EISAI INC.
$69
Neurelis, Inc.
$64
Avanir Pharmaceuticals, Inc.
$62
Janssen Pharmaceuticals, Inc
$59
US WorldMeds, LLC
$59
Abbott Laboratories
$59
Grifols USA, LLC
$56
Kyowa Kirin, Inc.
$51
Biohaven Pharmaceuticals, Inc.
$44
CSL Behring
$39
MITSUBISHI TANABE PHARMA AMERICA, INC.
$38
Aprecia Pharmaceuticals, LLC
$36
Eisai Inc.
$35
Boston Scientific Corporation
$35
Harmony Biosciences LLC
$34
Lundbeck LLC
$32
LivaNova USA, Inc.
$32
EMD Serono, Inc.
$29
Piramal Imaging Limited
$27
Bausch Health US, LLC
$23
Currax Pharmaceuticals LLC
$23
Cala Health, Inc.
$23
Supernus Pharmaceuticals, Inc.
$21
Horizon Therapeutics plc
$18
Akcea Therapeutics, Inc.
$17
Vanda Pharmaceuticals Inc.
$17
Zyla Life Sciences, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$17
BANNER LIFE SCIENCES, LLC
$16
Sunovion Pharmaceuticals Inc.
$16
Promius Pharma LLC
$16
Strongbridge US INC.
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Celgene Corporation
$12
Neuronetics, Inc.
$11
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 35.2% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APTIOM · AUSTEDO · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CALA TRIO · CONTRAVE · Cambia · Carnation Ambulatory Monitor · Cimzia · EMGALITY · Epidiolex · Fycompa · GILENYA · GOCOVRI · Gamunex-C · General - DBS · HETLIOZ · Hizentra · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · MIGRANAL · MYOBLOC · Mavenclad · NEURACEQ · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · Radicava · SOLIRIS · SPRIX · SYMPAZAN · Soliris · Spritam · TEGSEDI · TOPIRAMATE Extended Release Capsules · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · UBRELVY · UPLIZNA · VALTOCO · VERCISE · VNS Therapy · VYEPTI · Vimpat · Wakix · Xadago · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $751 per 100 Medicare services performed
Looking for a neurology in South Miami?
Compare neurologys in the South Miami area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
253
Per 100K population
9.4
County median income
$68,694
Nearest hospital
SOUTH MIAMI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Damski is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Damski experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Damski performed 320 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Damski receive payments from pharmaceutical companies?
Yes. Dr. Damski received a total of $6,643 from 60 companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Damski's costs compare to other neurologys in South Miami?
Dr. Damski's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Damski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →